People · Operator
Named in public records as an officer, director or promoter · active 2016–2020 · Healthtech, Investment Vehicle, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| FCA Health Innovations II QP, LP | — | Healthtech | Series C | $55.1M | $1.3B | 2020 |
| FCA Health Innovations II, LP | — | Healthtech | Series A | $8.5M | $167.9M | 2020 |
| Dioko Health Ventures I, LP | — | Investment Vehicle | Series A | $7.0M | $105.9M | 2016 |
| Novarus Healthcare, Inc. | — | Other Health Care | Pre-Seed | $250K | $7.7M | 2016 |
Thomas K. Hearn III at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas K. Hearn III on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matthew A> King | 3 | 14 |
| Nancy S. Allen | 3 | 7 |
| JOHN R. BURCH, JR. | 2 | 7 |
| James A Patton | 2 | 5 |
| Whitney L Haley | 2 | 4 |
| Andrew J Bouldin | 2 | 4 |
| Whitney H Kalb | 2 | 2 |
| Charles (Todd) W Johnson | 2 | 2 |
| Charles W Johnson | 1 | 6 |
| Todd Christian Johnson | 1 | 1 |
| John Christian Robertson | 1 | 1 |
| Matt Christian King | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.